Intellia Therapeutics NTLA
NASDAQ NTLA
$12.03 +0.61 (+5.34%)
At close: Sep 29, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) Total Current Liabilities (2015 - 2026)

Updated

Intellia Therapeutics (NTLA) reported Total Current Liabilities of $79.39 million for Q2 2026, down 16.9% from $95.5 million a year earlier but up 3.9% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Total Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Intellia Therapeutics posted Total Current Liabilities of $103.88 million, down 6.3% from FY2024.

  • Total Current Liabilities has declined for three consecutive years, though with a five-year compound annual growth rate of 10.1% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $110.85 million in FY2024 (-3.8%), $115.21 million in FY2023 (-9.0%), $126.55 million in FY2022 (+0.6%) and $125.83 million in FY2021 (+95.8%).
  • Five-year quarterly Total Current Liabilities spans a low of $76.45 million in Q1 2026 and a high of $131.13 million in Q3 2022.
  • Year over year, Total Current Liabilities has now declined in each of the last five quarters, with an average decline of 6.2% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q1 2022 (growth of 107.8%); the low point was Q1 2026 (a decline of 32.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $76.45 million (Q1 2026), $103.88 million (Q4 2025) and $93.73 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Intellia Therapeutics 1.60 Bn 1.60 Bn - 79.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.39 Mn
Mar 31, 2026 76.45 Mn
Dec 31, 2025 103.88 Mn
Sep 30, 2025 93.73 Mn
Jun 30, 2025 95.50 Mn
Mar 31, 2025 112.59 Mn
Dec 31, 2024 110.85 Mn
Sep 30, 2024 105.68 Mn
Jun 30, 2024 105.09 Mn
Mar 31, 2024 97.91 Mn
Dec 31, 2023 115.21 Mn
Sep 30, 2023 91.95 Mn
Jun 30, 2023 99.85 Mn
Mar 31, 2023 103.38 Mn
Dec 31, 2022 126.55 Mn
Sep 30, 2022 131.13 Mn
Jun 30, 2022 123.76 Mn
Mar 31, 2022 126.11 Mn
Dec 31, 2021 125.83 Mn
Sep 30, 2021 97.57 Mn
API Access

Intellia Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NTLA&period=max&api_key=YOUR_API_KEY